Chronic Pulmonary Insufficiency of Prematurity: Developing Optimal Endpoints for Drug Development

J Pediatr. 2017 Dec:191:15-21.e1. doi: 10.1016/j.jpeds.2017.08.006.

¹ Center for Hospital Based Specialties, Children's National Medical Center, Washington, DC. Electronic address: [email protected].
² The Floating Hospital for Children at Tufts Medical Center and the Tufts Clinical and Translational Science Institute, Boston, MA.
³ Department of Pediatrics, University of Lübeck, Lübeck, Germany.
⁴ Department of Pediatrics, Cincinnati Children's Hospital Medical Center, Cincinnati, OH.
⁵ Department of Pediatrics, Children's Hospital of Colorado, Aurora, CO.
⁶ Department of Pediatrics, The University of North Carolina at Chapel Hill, Chapel Hill, NC.
⁷ Department of Pediatrics, Miller School of Medicine, University of Miami, Jackson Memorial Hospital, Miami, FL.
⁸ Department of Pediatrics, Albert Einstein College of Medicine and Children's Hospital at Montefiore, Bronx, NY.
⁹ Department of Pediatrics, University of California, San Francisco, CA.
¹⁰ Neonatal Intensive Care Centre, King's College Hospital, London, UK.
¹¹ Chiesi Farmaceutici SpA, Parma, Italy.
¹² Hillingdon Hospital NHS Trust, Uxbridge, UK.
¹³ Department of Pediatrics, Stanford University School of Medicine, Palo Alto, CA.
¹⁴ Institute of Translational Medicine, University of Liverpool, Liverpool, UK.

No abstract available

Keywords: bronchopulmonary dysplasia; chronic lung disease; long term outcomes; respiratory failure.

Publication types